Can different stages of leprosy treatment influence the profile of oral health? Oral status in leprosy

• Fernanda-Zanol Matos ^[1] ; Andreza-Maria-Fábio Aranha ^[2] ; Álvaro-Henrique Borges ^[2] ; Fábio-Luiz-Miranda Pedro ^[2] ; Suzane A. Raslan ^[3] ; Fádua Hamida ^[4] ; Kadyja Veiga ^[1] ; Alessandra-Nogueira Porto ^[2]
  1. [1] Post graduate of the postgraduate program of the University of Cuiabá- Mato Grosso
  2. [2] PhD Professor of the Postgraduate Course of Dentistry - University of Cuiabá- Mato Grosso
  3. [3] Professor at UNIVAG-Várzea Grande Undergraduate Course - Mato Grosso
  4. [4] Academic of Dentistry - University of Cuiabá- Mato Grosso

  Mostrar afiliaciones +
• Localización: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, ISSN-e 1698-6946, Vol. 23, Nº. 4 (July), 2018
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • The aim of study was to evaluate the oral health status, salivary flow and halitosis among individuals diagnosed with leprosy as compared with healthy subjects.

    A sample of 160 individuals was allocated into four groups, as follows: (G1) individuals with complete leprosy treatment; (G2) individuals diagnosed with leprosy and under multi-drug therapy; (G3) individuals diagnosed with leprosy not yet under treatment; and (G4) healthy individuals. Then individuals were submitted to periodontal clinical examination (visible plaque index, bleeding index, depth of probing and clinical attachment level); DMFT index (decayed-missing-filled teeth index); evaluation of salivary flow and halitosis using a halimeter equipment (Interscan Corp, Chatsworth, CA, USA).

    The data were analyzed using Kruskal-Wallis and chi-square tests. The mean DMFT was found to be higher than 6.6, which is considered very high, with no significant difference between groups (P>0.05). As for salivary flow, 76.2% of the subjects presented normal flow rates, while 10% and 13.7% showed low and very low salivary flow rates, respectively, with hyposalivation being mostly observed in Groups 1 and 2. The highest prevalence of noticeable odor was found in healthy individuals (G4), and the most prevalent periodontal diagnosis was gingivitis (63.1%) in Group 3 (individuals with leprosy not yet under multi-drug therapy) followed by periodontitis (25%) in Group 1 (individuals who had completed leprosy treatment).

    It was observed that individuals with a history of leprosy present poor oral health similar to that of systemically healthy individuals.